HRP20100475T1 - SUPSTITUIRANI AMIDI TIENOPIROLKARBOKSILNE KISELINE, AMIDI PIROLOTIAZOLKARBOKSILNE KISELINE I SRODNI ANALOZI, KAO INHIBITORI KAZEIN-KINAZE I ε - Google Patents

SUPSTITUIRANI AMIDI TIENOPIROLKARBOKSILNE KISELINE, AMIDI PIROLOTIAZOLKARBOKSILNE KISELINE I SRODNI ANALOZI, KAO INHIBITORI KAZEIN-KINAZE I ε Download PDF

Info

Publication number
HRP20100475T1
HRP20100475T1 HR20100475T HRP20100475T HRP20100475T1 HR P20100475 T1 HRP20100475 T1 HR P20100475T1 HR 20100475 T HR20100475 T HR 20100475T HR P20100475 T HRP20100475 T HR P20100475T HR P20100475 T1 HRP20100475 T1 HR P20100475T1
Authority
HR
Croatia
Prior art keywords
c6alkyl
carboxylic acid
acid amide
thieno
pyrrole
Prior art date
Application number
HR20100475T
Other languages
English (en)
Croatian (hr)
Inventor
Marc Fink David
Chiang Yulin
Dawn Collar Nicola
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of HRP20100475T1 publication Critical patent/HRP20100475T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
HR20100475T 2004-08-19 2005-08-18 SUPSTITUIRANI AMIDI TIENOPIROLKARBOKSILNE KISELINE, AMIDI PIROLOTIAZOLKARBOKSILNE KISELINE I SRODNI ANALOZI, KAO INHIBITORI KAZEIN-KINAZE I ε HRP20100475T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19
PCT/US2005/029383 WO2006021000A2 (en) 2004-08-19 2005-08-18 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number Publication Date
HRP20100475T1 true HRP20100475T1 (hr) 2010-10-31

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100475T HRP20100475T1 (hr) 2004-08-19 2005-08-18 SUPSTITUIRANI AMIDI TIENOPIROLKARBOKSILNE KISELINE, AMIDI PIROLOTIAZOLKARBOKSILNE KISELINE I SRODNI ANALOZI, KAO INHIBITORI KAZEIN-KINAZE I ε

Country Status (30)

Country Link
US (2) US7393867B2 (enExample)
EP (1) EP1784409B1 (enExample)
JP (1) JP4869232B2 (enExample)
KR (1) KR20070045263A (enExample)
CN (1) CN100562521C (enExample)
AR (1) AR051008A1 (enExample)
AT (1) ATE471326T1 (enExample)
AU (1) AU2005272584B2 (enExample)
BR (1) BRPI0514419A (enExample)
CA (1) CA2577879C (enExample)
CY (1) CY1110775T1 (enExample)
DE (1) DE602005021889D1 (enExample)
DK (1) DK1784409T3 (enExample)
ES (1) ES2347166T3 (enExample)
GT (1) GT200500215A (enExample)
HR (1) HRP20100475T1 (enExample)
IL (1) IL181158A0 (enExample)
JO (1) JO2629B1 (enExample)
MY (1) MY139831A (enExample)
PA (1) PA8642801A1 (enExample)
PE (1) PE20060630A1 (enExample)
PL (1) PL1784409T3 (enExample)
PT (1) PT1784409E (enExample)
RS (1) RS51413B (enExample)
RU (1) RU2403257C2 (enExample)
SI (1) SI1784409T1 (enExample)
SV (1) SV2006002190A (enExample)
TW (1) TWI372149B (enExample)
UY (1) UY29077A1 (enExample)
WO (1) WO2006021000A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
EP2397481B1 (en) * 2009-02-12 2014-03-12 Pharmadesign, Inc. Inhibitor of casein kinase 1delta and casein kinase 1epsilon
EP2435443B1 (en) * 2009-05-28 2013-07-31 Vertex Pharmaceuticals Incorporated Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
HRP20140252T1 (hr) * 2009-10-28 2014-04-25 Pfizer Inc. Derivati imidazola kao inhibitori kazeinske kinaze
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
RU2562833C2 (ru) 2010-08-09 2015-09-10 НБ Хелс Лаборатори Ко. Лтд. Ингибитор казеинкиназы 1 дельта и казеинкиназы 1 е
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
WO2000075669A1 (en) * 1999-06-08 2000-12-14 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins
AU2004303826A1 (en) * 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I Epsilon

Also Published As

Publication number Publication date
CY1110775T1 (el) 2015-06-10
TW200621788A (en) 2006-07-01
GT200500215A (es) 2006-03-27
DK1784409T3 (da) 2010-09-27
PE20060630A1 (es) 2006-08-03
HK1105198A1 (en) 2008-02-06
JP2008510712A (ja) 2008-04-10
EP1784409B1 (en) 2010-06-16
EP1784409A2 (en) 2007-05-16
CA2577879A1 (en) 2006-02-23
AU2005272584B2 (en) 2010-11-11
BRPI0514419A (pt) 2008-06-10
TWI372149B (en) 2012-09-11
PA8642801A1 (es) 2006-05-16
KR20070045263A (ko) 2007-05-02
US20070299112A1 (en) 2007-12-27
JP4869232B2 (ja) 2012-02-08
JO2629B1 (en) 2012-06-24
PL1784409T3 (pl) 2010-10-29
US7393867B2 (en) 2008-07-01
SI1784409T1 (sl) 2010-10-29
ATE471326T1 (de) 2010-07-15
RU2403257C2 (ru) 2010-11-10
AU2005272584A1 (en) 2006-02-23
CN101001861A (zh) 2007-07-18
RU2007109812A (ru) 2008-09-27
SV2006002190A (es) 2006-05-24
IL181158A0 (en) 2007-07-04
US7652046B2 (en) 2010-01-26
CA2577879C (en) 2011-07-12
CN100562521C (zh) 2009-11-25
WO2006021000A3 (en) 2006-06-15
RS51413B (sr) 2011-02-28
MY139831A (en) 2009-10-30
DE602005021889D1 (en) 2010-07-29
WO2006021000A2 (en) 2006-02-23
PT1784409E (pt) 2010-09-06
US20080227822A1 (en) 2008-09-18
AR051008A1 (es) 2006-12-13
ES2347166T3 (es) 2010-10-26
UY29077A1 (es) 2006-03-31

Similar Documents

Publication Publication Date Title
HRP20100475T1 (hr) SUPSTITUIRANI AMIDI TIENOPIROLKARBOKSILNE KISELINE, AMIDI PIROLOTIAZOLKARBOKSILNE KISELINE I SRODNI ANALOZI, KAO INHIBITORI KAZEIN-KINAZE I ε
RU2470023C2 (ru) 1-цианоциклопропильные производные в качестве ингибиторов катепсина к
ES2350460T3 (es) Derivados de 3-aza-biciclo[3.1.0]hexano.
ES2734735T3 (es) Derivados de 4-oxo-3,4-dihidro-1,2,3,-benzotriazina como moduladores de GPR139
PE20120172A1 (es) Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide
AR068635A1 (es) Derivados de 1, 1, 1 - trifluor - 2 - hidroxi - 3 - fenilpropano, un metodo para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades asociadas con la modulacion del receptor de glucocorticoides.
BRPI0710527A2 (pt) compostos de pirrolo-e tiazolo-piridina e métodos para sua utilização
PE20091833A1 (es) Derivados heterociclicos espiro biciclicos o heterociclicos biciclicos, puenteados, de pirazolo [1,5-a]pirimidinas como inhibidores de quinasas raf y metodos para su preparacion
CN111886224A (zh) Atr激酶的杂环抑制剂
CA2779303A1 (en) Bicyclic pyridines and analogs as sirtuin modulators
EP2640392A2 (en) Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
PE20120534A1 (es) PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt
AU2020332462B2 (en) Azaheteroaryl compound and application thereof
CN106699785A (zh) 作为CDK4/6抑制剂的2-(N-氧化吡啶-2基氨基)-吡啶并[2,3-d]嘧啶-7-酮类化合物
NI200800021A (es) Derivados de n - (arilalquil) - 1h - pirrolopiridin - 2 - carboxamidas, su preparación y su aplicación en terapéutica
RU2009140095A (ru) Гетероарильные производные
AR084515A1 (es) Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
CA3191362A1 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
AU2011340063B2 (en) Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
JP7273454B2 (ja) 物質使用再発のための非筋ミオシンｉｉ阻害剤
AU2017245318A1 (en) Heteroaryl compounds and methods of use thereof
Tsou et al. 4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)
EA201070217A1 (ru) Производные трициклических n-гетероарилкарбоксамидов, их получение и их применение в терапии
CA2595075A1 (en) Pyrrolodihydroisoquinolines as antiproliferative agents
WO2014191632A1 (en) Use of condensed benzo[b]thiazine derivatives as cytoprotectants